AQST Valuation

Aquestive Therapeutics Inc (AQST) has a current Price-to-Book (P/B) ratio of -183.72. Compared to its 3-year average P/B ratio of -17.41 , the current P/B ratio is approximately 955.33% higher. Relative to its 5-year average P/B ratio of -11.22, the current P/B ratio is about 1537.30% higher. Aquestive Therapeutics Inc (AQST) has a Forward Free Cash Flow (FCF) yield of approximately -6.72%. Compared to its 3-year average FCF yield of -6.20%, the current FCF yield is approximately 8.50% lower. Relative to its 5-year average FCF yield of -20.01% , the current FCF yield is about -66.39% lower.